Trial23 - A Method Study on Cervical Screening in Women Offered HPV-vaccination as Girls

NAActive, not recruitingINTERVENTIONAL
Enrollment

7,000

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cervical Intraepithelial Neoplasia (CIN)
Interventions
DEVICE

Cobas HPV-DNA test

"Cobas HPV-DNA testing device from Roche is already in standard use in the Danish screening program for purpose of triage and primary screening of women 60+. It has four signals; HPV-negative, HPV-16, HPV-18 and other"

Trial Locations (1)

1014

University of Copenhagen, Copenhagen

All Listed Sponsors
collaborator

Naestved Hospital

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

Soenderjylland Hospital

UNKNOWN

collaborator

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER

collaborator

Randers Regional Hospital

OTHER

lead

University of Copenhagen

OTHER